Integrating therapies for surgical adult soft tissue sarcoma patients

Daniel P. Milgrom, Amikar Sehdev, Joshua K. Kays, Leonidas Koniaris

Research output: Contribution to journalReview article

2 Scopus citations


Sarcomas are an uncommon group of over 50 different individual histological malignancies arising from mesenchymal (non-epithelial or connective) tissues. Overall, they constitute 1% of human malignancies with an annual incidence rate of fewer than 5 patients per million. Sarcoma may arise from any mesenchymal cell lineages including fat, muscle, or other connective tissues. Due to the rarity of these groups of malignancies, many subtypes were, and still today, are managed as a single entity. This review focused on soft tissue sarcomas with an emphasis on how to integrate therapies for patients with this rare disorder. The role for surgical resection in cure and palliation as well as the relative benefits of adjuvant therapies such as chemotherapy and radiation therapy are discussed.

Original languageEnglish (US)
Article number88
JournalTranslational Gastroenterology and Hepatology
Issue numberNovember
StatePublished - Nov 1 2018


  • Disparities
  • Gastrointestinal stromal tumors (GIST)
  • Liposarcoma
  • Malignant fibrohistiosarcoma (MFH)
  • Sarcoma
  • Stromal

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Integrating therapies for surgical adult soft tissue sarcoma patients'. Together they form a unique fingerprint.

  • Cite this